Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Healthcare Industry News Max India gets Rs 124cr lifeline: Can it turn around after 8 loss quarters? Max India’s rights issue sees 1.45x oversubscription despite 8 quarters of losses. Find out how the funds will reshape India’s senior care ecosystem. byPallavi MadhirajuMay 31, 2025